Judith I Tsui1, Debbie M Cheng, Howard Libman, Carly Bridden, Richard Saitz, Jeffrey H Samet. 1. Clinical Addiction Research and Education (CARE) Unit, Section of General Internal Medicine, Department of Medicine, Boston Medical Center, and Boston University School of Medicine, Boston, Massachusetts 02118, USA. judith.tsui@bmc.org
Abstract
OBJECTIVE: The purpose of this study was to examine the association between risky drinking amounts and serum aminotransferase levels in HIV-infected adults with and without hepatitis C virus (HCV) infection. METHOD: In a prospective cohort of HIV-infected adults with current or past alcohol problems, we assessed whether drinking risky amounts (as defined by the National Institute on Alcohol Abuse and Alcoholism) was associated with higher levels of serum aspartate aminotransferase [AST] and alanine aminotransferase [ALT]) over time, stratifying analyses by HCV status. Generalized linear mixed effects regression models were used to examine the association between risky drinking and natural log-transformed AST and ALT over time. RESULTS: Among HIV/HCV-coinfected persons (n = 200), risky drinking was associated with a higher adjusted mean AST (62.2 vs. 51.4 U/L; adjusted ratio of means 1.2, 95% CI [1.07, 1.37], p = .003) and ALT (51.3 vs. 41.6 U/L; adjusted ratio of means 1.2, 95% CI [1.07, 1.42], p = .004) compared with non-risky drinking. In contrast, among HIV-infected adults without HCV infection (n = 197), there were no significant differences between those who did and did not drink risky amounts in AST (34.7 vs. 33.3 U/L; adjusted ratio of means = 1.0, 95% CI [0.95, 1.14], p = .36) or ALT (29.1 vs. 28.7 U/L; adjusted ratio of means = 1.0, 95% CI [0.91, 1.13], p = .78). CONCLUSIONS: Among HIV-infected adults with HCV, those who drink risky amounts have higher serum aminotransferase levels than those who do not drink risky amounts. These results suggest that drinking risky amounts may be particularly harmful in HIV/HCV-coinfected adults and supports recommendations that providers pay special attention to drinking in this population.
OBJECTIVE: The purpose of this study was to examine the association between risky drinking amounts and serum aminotransferase levels in HIV-infected adults with and without hepatitis C virus (HCV) infection. METHOD: In a prospective cohort of HIV-infected adults with current or past alcohol problems, we assessed whether drinking risky amounts (as defined by the National Institute on Alcohol Abuse and Alcoholism) was associated with higher levels of serum aspartate aminotransferase [AST] and alanine aminotransferase [ALT]) over time, stratifying analyses by HCV status. Generalized linear mixed effects regression models were used to examine the association between risky drinking and natural log-transformed AST and ALT over time. RESULTS: Among HIV/HCV-coinfectedpersons (n = 200), risky drinking was associated with a higher adjusted mean AST (62.2 vs. 51.4 U/L; adjusted ratio of means 1.2, 95% CI [1.07, 1.37], p = .003) and ALT (51.3 vs. 41.6 U/L; adjusted ratio of means 1.2, 95% CI [1.07, 1.42], p = .004) compared with non-risky drinking. In contrast, among HIV-infected adults without HCV infection (n = 197), there were no significant differences between those who did and did not drink risky amounts in AST (34.7 vs. 33.3 U/L; adjusted ratio of means = 1.0, 95% CI [0.95, 1.14], p = .36) or ALT (29.1 vs. 28.7 U/L; adjusted ratio of means = 1.0, 95% CI [0.91, 1.13], p = .78). CONCLUSIONS: Among HIV-infected adults with HCV, those who drink risky amounts have higher serum aminotransferase levels than those who do not drink risky amounts. These results suggest that drinking risky amounts may be particularly harmful in HIV/HCV-coinfected adults and supports recommendations that providers pay special attention to drinking in this population.
Authors: Lucy E Wilson; Michael Torbenson; Jacquie Astemborski; Hawazin Faruki; Charles Spoler; Rudra Rai; Shruti Mehta; Gregory D Kirk; Kenrad Nelson; Nezam Afdhal; David L Thomas Journal: Hepatology Date: 2006-04 Impact factor: 17.425
Authors: Carol E Blixen; Noah J Webster; Andrew J Hund; Adam T Perzynski; Stephanie W Kanuch; Eleanor Palo Stoller; Richard A McCormick; Neal V Dawson Journal: J Gen Intern Med Date: 2008-08 Impact factor: 5.128
Authors: Adam T Perzynski; Richard McCormick; Noah J Webster; Carol E Blixen; Stephanie Kanuch; Charles L Thomas; Kevin D Mullen; Neal V Dawson Journal: J Stud Alcohol Drugs Date: 2011-09 Impact factor: 2.582
Authors: Lydia N Drumright; Holly Hagan; David L Thomas; Mary H Latka; Elizabeth T Golub; Richard S Garfein; John D Clapp; Jennifer V Campbell; Sebastian Bonner; Farzana Kapadia; Thelma King Thiel; Steffanie A Strathdee Journal: J Hepatol Date: 2010-11-24 Impact factor: 25.083
Authors: Gregory L Armstrong; Annemarie Wasley; Edgar P Simard; Geraldine M McQuillan; Wendi L Kuhnert; Miriam J Alter Journal: Ann Intern Med Date: 2006-05-16 Impact factor: 25.391
Authors: Christopher W Kahler; Tao Liu; Patricia A Cioe; Vaughn Bryant; Megan M Pinkston; Erna M Kojic; Nur Onen; Jason V Baker; John Hammer; John T Brooks; Pragna Patel Journal: AIDS Behav Date: 2017-07
Authors: Jennifer C Elliott; Efrat Aharonovich; Ann O'Leary; Barbara Johnston; Deborah S Hasin Journal: Alcohol Clin Exp Res Date: 2014-12 Impact factor: 3.455
Authors: Christopher W Kahler; David W Pantalone; Nadine R Mastroleo; Tao Liu; Gerald Bove; Bharat Ramratnam; Peter M Monti; Kenneth H Mayer Journal: J Consult Clin Psychol Date: 2018-08
Authors: Emily C Williams; Judith A Hahn; Richard Saitz; Kendall Bryant; Marlene C Lira; Jeffrey H Samet Journal: Alcohol Clin Exp Res Date: 2016-09-22 Impact factor: 3.455
Authors: Milensu Shanyinde; Enrico Girardi; Massimo Puoti; Andrea De Luca; Laura Sighinolfi; Uberti Foppa Caterina; Pietro Caramello; Fiona C Lampe; Antonella D'Arminio Monforte; Alessandro Cozzi-Lepri Journal: BMC Public Health Date: 2019-10-15 Impact factor: 3.295
Authors: Ni Gusti Ayu Nanditha; Adrianna Paiero; Hiwot M Tafessu; Martin St-Jean; Taylor McLinden; Amy C Justice; Jacek Kopec; Julio S G Montaner; Robert S Hogg; Viviane D Lima Journal: BMJ Open Date: 2021-01-08 Impact factor: 3.006